• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Elucidation of mechanism of pathogenesis of paroxysmal nocturnal hemoglobinuria

Research Project

Project/Area Number 17K09904
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Hematology
Research InstitutionOsaka University

Principal Investigator

Takamori Hiroyuki  大阪大学, 医学部附属病院, 医員 (80792077)

Co-Investigator(Kenkyū-buntansha) 植田 康敬  大阪大学, 医学系研究科, 助教 (30533848)
西村 純一  大阪大学, 医学系研究科, 助教 (80464246)
金倉 譲  大阪大学, 医学系研究科, 教授 (20177489)
Project Period (FY) 2017-04-01 – 2020-03-31
Project Status Completed (Fiscal Year 2019)
Budget Amount *help
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2019: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2018: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2017: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Keywords発作性夜間ヘモグロビン尿症 / 血液 / PNH / 骨髄不全症 / bone marrow failure / 遺伝子解析 / 次世代シークエンサー / 補体 / 内科 / 遺伝学 / 次世代シーケンサー / ゲノム
Outline of Final Research Achievements

Paroxysmal nocturnal hemoglobinuria (PNH) is considered to be an acquired stem cell disease based on series of experiments including those using mouse models. We performed whole exome sequencing and targeted deep sequencing for intrafamilial PNH patients for the first time in Japan. However, we could not identify gene mutations that might be involved in the etiology of PNH in intrafamilial pair. Based on the above, it is highly possible that these cases have developed sporadic PNH in a parent and a child, and the results further support the conventional understanding that PNH is an acquired disease.

Academic Significance and Societal Importance of the Research Achievements

PNHの主たる原因は、PIGA(Phosphatidylinositol glycan anchor biosynthesis, class A)遺伝子を始めとした、GPI (glycosylphosphatidylinositol) アンカー型蛋白質の生合成に関わる遺伝子の変異である。PIGAノックアウトマウスは胎生致死を来すため、PNHは後天性疾患であるとされてきた。本症例の遺伝子解析でも親子で異なるPIGA遺伝子変異を認めており、PNHにおいてもPIGA遺伝子変異が遺伝する可能性は極めて低いことが示唆される。

Report

(4 results)
  • 2019 Annual Research Report   Final Research Report ( PDF )
  • 2018 Research-status Report
  • 2017 Research-status Report
  • Research Products

    (3 results)

All 2018

All Presentation (3 results) (of which Int'l Joint Research: 1 results)

  • [Presentation] An optimal management of PNH patients on anti-C5 antibody2018

    • Author(s)
      Hiroyuki Takamori, Yasutaka Ueda, Makiko Osato, Satoru Hayashi, Junichi Nishimura, Yuzuru Kanakura
    • Organizer
      第80回 日本血液学会学術集会
    • Related Report
      2018 Research-status Report
  • [Presentation] 抗補体薬C5治療下のPNH患者における尿中ヘモジデリン検出の有用性2018

    • Author(s)
      植田 康敬、堀田 真希、小林 渉、高森 弘之、西村 純一、日高 洋、金倉 譲
    • Organizer
      第80回 日本血液学会学術集会
    • Related Report
      2018 Research-status Report
  • [Presentation] Current Status and Optimal Management of Eculizumab Poor-Responders Due to C5 Polymorphisms2018

    • Author(s)
      Yasutaka Ueda, Hiroyuki Takamori, Jun-Ho Jang, Chezi Ganzel, Saskia Langemeijer, Makiko Osato, Petra Muus, Jong-Wook Lee, Jun-Ichi Nishimura and Yuzuru Kanakura
    • Organizer
      ASH-60th American Society of Hematology Annual Meeting & Exposition
    • Related Report
      2018 Research-status Report
    • Int'l Joint Research

URL: 

Published: 2017-04-28   Modified: 2021-02-19  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi